RVTY vs CRL — Key Metrics

Metric RVTY (REVVITY INC) CRL (CHARLES RIVER LABORATORIES INTERNATIONAL INC)
Price152.43333.25
Market Cap17.02 Billion15.97 Billion
P/E (TTM)67.75311.45
P/B (Quarterly)2.4434.845
P/S (TTM)5.784.02
Net Profit Margin (TTM)8.61.0
Gross Margin (TTM)55.933.3
ROE (TTM)3.51.3
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

REVVITY INC
vs
 
CHARLES RIVER LABORATORIES INTERNATIONAL INC
 
REVVITY INC
vs
 
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Performance Comparison
AI Model Recommendation
RVTY · REVVITY INC

Underperform

-46
UnderperformOutperform
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL INC

Greatly Underperform

-80
UnderperformOutperform
Recommendation Summary

Stock RVTY is projected to underperform the market, stock CRL is projected to greatly underperform the market. Upfront Recommendation: RVTY.

Financial Metrics
Prices delayed ~15 min
RVTY Metrics CRL
$152.43 Price $333.25
— Market Capitalization —
67.75 Price to Earnings Ratio 311.45
5.78 Price to Sales 4.02
28.24 Price to FCF Ratio 39.96
10.35 Price to Gross Profit 12.05
9.14 Price to Current Assets 10.4

RVTY vs CRL at a glance

Revvity INC (RVTY) and Charles River Laboratories International INC (CRL) are both Diagnostics & Research companies in the Healthcare sector. They are similar in size: $17.0 billion and $16.0 billion in market value.

On trailing-twelve-month figures, RVTY trades at 67.8 times trailing earnings and CRL at 311.4; net profit margins are 8.6% and 1.0%.

The Upfront Investment model currently rates RVTY Underperform and CRL Greatly Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.